CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
62.93
-4.00 (-5.98%)
At close: May 18, 2026, 4:00 PM EDT
63.39
+0.46 (0.73%)
Pre-market: May 19, 2026, 4:27 AM EDT
CG Oncology Market Cap
CG Oncology has a market cap or net worth of $5.55 billion as of May 19, 2026. Its market cap has increased by 162.51% in one year.
Market Cap
5.55B
Enterprise Value
4.48B
1-Year Change
162.51%
Ranking
Category
Stock Price
$62.93
Market Cap Chart
Since the IPO on January 25, 2024, CG Oncology's market cap has increased from $1.21B to $5.55B, an increase of 360.18%. That is a compound annual growth rate of 93.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 5.90B | 76.26% |
| Dec 31, 2025 | 3.35B | 53.40% |
| Dec 31, 2024 | 2.18B | 81.02% |
| Jan 25, 2024 | 1.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mirum Pharmaceuticals | 6.23B |
| Rhythm Pharmaceuticals | 6.20B |
| Centessa Pharmaceuticals | 6.13B |
| Apogee Therapeutics | 6.08B |
| Corcept Therapeutics | 6.05B |
| PTC Therapeutics | 5.93B |
| Scholar Rock Holding | 5.91B |
| Belite Bio | 5.63B |